Health Condition 1: N189- Chronic kidney disease, unspecified
Conditions
Interventions
Intervention1: RENODIET-HP: Oral Nutritional Supplement (RenoDiet-HP) 32g in 65ml of normal water twice daily
Control Intervention1: NOT APPLICABLE: NOT APPLICABLE
Sponsors
Pulse Pharmaceuticals Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. All consenting patients with CKD, above 18 years of age, and receiving twice or thrice weekly maintenance hemodialysis for atleast 6 months at the outpatient hemodialysis unit will be included in the study. 2. Patients willing to sign the Informed Consent Form (ICF).
Exclusion criteria
Exclusion criteria: 1. Patients with intercurrent acute illnesses. 2. Bodyweight less than 40 kg. 3. Documented history of dialysis non-compliance. 4. Documented malabsorption syndrome. 5. Contraindications to any ingredient of RenoDiet-HP. 6. Chronic illness that, in the opinion of the investigator, is at a stage where it might interfere with trial conduct or completion. (Chronic illness may include but is not limited to, cardiac, renal, autoimmune, hepatic, haematological, genetic disorders, atopic conditions, congenital defects, diabetes, convulsions or encephalopathy, tuberculosis etc.). 7. Pregnant & Lactating women. 8. Patients who are not willing to sign the ICF.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess any changes in the levels of serum albumin, haemoglobin, phosphorus, potassium, and total iron-binding capacity (TIBC), and body weight after treating with RenoDiet-HP for 03 months.Timepoint: 3 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the Malnutrition Inflammation Score (MIS) & Subjective Global Assessment (SGA).Timepoint: 3 MONTHS | — |
Countries
India
Contacts
Public ContactDr Geeta Sheth
Sir Jamshedjee Jeejeebhoy Group of Hospital
Outcome results
None listed